Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

被引:266
|
作者
Ferslew, Brian C. [1 ,2 ]
Xie, Guoxiang [3 ]
Johnston, Curtis K. [1 ]
Su, Mingming [3 ]
Stewart, Paul W. [4 ]
Jia, Wei [3 ]
Brouwer, Kim L. R. [1 ]
Barritt, A. Sidney [5 ]
机构
[1] Univ N Carolina, UNC Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27599 USA
[2] Theravance Biopharma US Inc, Clin Pharmacol & Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA
[3] Univ Hawaii, Ctr Canc, Metabol Shared Resource, Honolulu, HI 96813 USA
[4] Univ N Carolina, UNC Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, UNC Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
Nonalcoholic steatohepatitis; Bile acids; Bile acid metabolome; Enterohepatic recirculation; FATTY LIVER-DISEASE; URSODEOXYCHOLIC ACID; ACTIVATION; APOPTOSIS; RECEPTOR; CANCER; INJURY; METAANALYSIS; HOMEOSTASIS; POPULATION;
D O I
10.1007/s10620-015-3776-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The prevalence of nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) is increasing at an alarming rate. The role of bile acids in the development and progression of NAFLD to NASH and cirrhosis is poorly understood. This study aimed to quantify the bile acid metabolome in healthy subjects and patients with non-cirrhotic NASH under fasting conditions and after a standardized meal. Liquid chromatography tandem mass spectroscopy was used to quantify 30 serum and 16 urinary bile acids from 15 healthy volunteers and 7 patients with biopsy-confirmed NASH. Bile acid concentrations were measured at two fasting and four post-prandial time points following a high-fat meal to induce gallbladder contraction and bile acid reabsorption from the intestine. Patients with NASH had significantly higher total serum bile acid concentrations than healthy subjects under fasting conditions (2.2- to 2.4-fold increase in NASH; NASH 2595-3549 A mu M and healthy 1171-1458 A mu M) and at all post-prandial time points (1.7- to 2.2-fold increase in NASH; NASH 4444-5898 A mu M and healthy 2634-2829 A mu M). These changes were driven by increased taurine- and glycine-conjugated primary and secondary bile acids. Patients with NASH exhibited greater variability in their fasting and post-prandial bile acid profile. Results indicate that patients with NASH have higher fasting and post-prandial exposure to bile acids, including the more hydrophobic and cytotoxic secondary species. Increased bile acid exposure may be involved in liver injury and the pathogenesis of NAFLD and NASH.
引用
收藏
页码:3318 / 3328
页数:11
相关论文
共 50 条
  • [41] Bileome: The bile acid metabolome of rat
    Gaikwad, Nilesh W.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 533 (03) : 458 - 466
  • [42] EFFECT OF TROPIFEXOR ON CIRCADIAN VARIATION OF BILE ACIDS AND ITS RELATIONSHIP WITH PRURITUS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS
    Prince, William T.
    Pachori, Alok
    Xing, Jinming
    Stringer, Rowan
    Jennings, Nicki
    Fischer, Audrey
    Schwald, Marianne
    Lienard, Mathilde
    Schadt, Heiko
    Brees, Dominique
    [J]. HEPATOLOGY, 2021, 74 : 1106A - 1107A
  • [43] Serum bile acids are markedly elevated in patients with compensated cirrhosis due to nonalcoholic steatohepatitis (NASH)
    Sanyal, A.
    Harrison, S.
    Charlton, M.
    Caldwell, S.
    Chuang, J.
    Wang, L.
    Chen, G.
    Chung, C.
    Djedjos, S.
    Myers, R.
    Afdhal, N.
    Bosch, J.
    Ratziu, V.
    Loomba, R.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S550 - S551
  • [44] Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis
    Li, Junyou
    Liu, Mengqi
    Li, Yazhou
    Sun, Dan-dan
    Shu, Zhihao
    Tan, Qian
    Guo, Shimeng
    Xie, Rongrong
    Gao, Lixin
    Ru, Hongbo
    Zang, Yi
    Liu, Hong
    Li, Jia
    Zhou, Yu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12748 - 12772
  • [45] Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    Etsuko Hashimoto
    Satoru Yatsuji
    Maki Tobari
    Makiko Taniai
    Nobuyuki Torii
    Katsutoshi Tokushige
    Keiko Shiratori
    [J]. Journal of Gastroenterology, 2009, 44 : 89 - 95
  • [46] Nonalcoholic steatohepatitis in nondiabetic obese patients
    Zamin, I
    de Mattos, AA
    Zettler, CG
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2002, 16 (05): : 303 - 307
  • [47] Resistance to insulin in patients with nonalcoholic steatohepatitis
    Perez-Carreras, M
    Del-Hoyo, P
    Vargas, C
    Martin, A
    Castellano, G
    Arenas, J
    Solis-Herruzo, JA
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 192 - 192
  • [48] Laparoscopic findings in patients with nonalcoholic steatohepatitis
    Tanaka, N
    Ichijo, T
    Okiyama, W
    Mutou, H
    Misawa, N
    Matsumoto, A
    Yoshizawa, K
    Tanaka, E
    Kiyosawa, K
    [J]. LIVER INTERNATIONAL, 2006, 26 (01) : 32 - 38
  • [49] Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
    Hashimoto, Etsuko
    Yatsuji, Satoru
    Tobari, Maki
    Taniai, Makiko
    Torii, Nobuyuki
    Tokushige, Katsutoshi
    Shiratori, Keiko
    [J]. JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 89 - 95
  • [50] NONALCOHOLIC STEATOHEPATITIS - A STUDY OF 49 PATIENTS
    LEE, RG
    [J]. HUMAN PATHOLOGY, 1989, 20 (06) : 594 - 598